Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview

Perindopril erbumine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for perindopril erbumine and what is the scope of perindopril erbumine patent protection?

Perindopril erbumine
is the generic ingredient in two branded drugs marketed by Ani Pharms Inc, Apotex, Lupin Ltd, Aurobindo Pharma, West-ward Pharms Int, and Symplmed Pharms Llc, and is included in six NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for perindopril erbumine. Seven suppliers are listed for this compound.

Summary for Generic Name: perindopril erbumine

Drug Master File Entries: see list14
Suppliers / Packagers: see list7
Bulk Api Vendors: see list33
Clinical Trials: see list17
Patent Applications: see list1,339
Therapeutic Class:Cardiovascular Agents
Drug Prices:see low prices
DailyMed Link:perindopril erbumine at DailyMed

Pharmacology for Ingredient: perindopril erbumine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
perindopril erbumine
TABLET;ORAL090072-001Nov 10, 2009ABRXNoNo► Subscribe► Subscribe
perindopril erbumine
TABLET;ORAL090463-002Aug 30, 2010ABRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
perindopril erbumine
TABLET;ORAL090072-003Nov 10, 2009ABRXNoNo► Subscribe► Subscribe
Ani Pharms Inc
perindopril erbumine
TABLET;ORAL078138-003Nov 10, 2009ABRXNoNo► Subscribe► Subscribe
Symplmed Pharms Llc
perindopril erbumine
TABLET;ORAL020184-001Dec 30, 1993ABRXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus